Special Lecture by Dr. Patricia Volkow

Patricia Volkow, MD, is an infectious disease specialist at the National Cancer Institute in Mexico City. In 1990, she formed the AIDS Cancer Clinic at the National Institute of Cancer, and started her research on the impact of plasma and blood trade in the AIDS epidemic in a hospital where 60% of AIDS patients were infected through tainted blood transfusion. For the last twenty years she has worked at the National Institute of Cancer in Mexico and has held the position of Under-director of the Diagnostic and Therapeutic Services since 2005. She has been member of the Clinical Committee of Conasida (National Council to fight AIDS) and has participated in the National Guidelines to treat HIV/AIDS patients. She is now member of the Council to Fight AIDS of the Mexico City AIDS Program.

 

 


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below